Literature DB >> 20345583

Update on tuberculous pleural effusion.

Richard W Light1.   

Abstract

The possibility of tuberculous pleuritis should be considered in every patient with an undiagnosed pleural effusion, for if this diagnosis is not made the patient will recover only to have a high likelihood of subsequently developing pulmonary or extrapulmonary tuberculosis Between 3% and 25% of patients with tuberculosis will have tuberculous pleuritis. The incidence of pleural tuberculosis is higher in patients who are HIV positive. Tuberculous pleuritis usually presents as an acute illness with fever, cough and pleuritic chest pain. The pleural fluid is an exudate that usually has predominantly lymphocytes. Pleural fluid cultures are positive for Mycobacterium tuberculosis in less than 40% and smears are virtually always negative. The easiest way to establish the diagnosis of tuberculous pleuritis in a patient with a lymphocytic pleural effusion is to generally demonstrate a pleural fluid adenosine deaminase level above 40 U/L. Lymphocytic exudates not due to tuberculosis almost always have adenosine deaminase levels below 40 U/L. Elevated pleural fluid levels of gamma-interferon also are virtually diagnostic of tuberculous pleuritis in patients with lymphocytic exudates. In questionable cases the diagnosis can be established by demonstrating granulomas or organisms on tissue specimens obtained via needle biopsy of the pleura or thoracoscopy. The chemotherapy for tuberculous pleuritis is the same as that for pulmonary tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20345583     DOI: 10.1111/j.1440-1843.2010.01723.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  103 in total

1.  Xpert MTB/RIF assay for diagnosis of pleural tuberculosis.

Authors:  Sven O Friedrich; Florian von Groote-Bidlingmaier; Andreas H Diacon
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

2.  Bayesian meta-analysis of the accuracy of a test for tuberculous pleuritis in the absence of a gold standard reference.

Authors:  Nandini Dendukuri; Ian Schiller; Lawrence Joseph; Madhukar Pai
Journal:  Biometrics       Date:  2012-05-08       Impact factor: 2.571

Review 3.  Tuberculous pleural effusions: advances and controversies.

Authors:  Morné J Vorster; Brian W Allwood; Andreas H Diacon; Coenraad F N Koegelenberg
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

4.  Role of medical thoracoscopy in the treatment of tuberculous pleural effusion.

Authors:  Yu Xiong; Xusheng Gao; Huaiyang Zhu; Caihong Ding; Jian Wang
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

5.  Recruitment of IL-27-Producing CD4(+) T Cells and Effect of IL-27 on Pleural Mesothelial Cells in Tuberculous Pleurisy.

Authors:  Zhi-Jian Ye; Li-Li Xu; Qiong Zhou; Ai Cui; Xiao-Juan Wang; Kan Zhai; Zhen Wang; Zhao-Hui Tong; Huan-Zhong Shi
Journal:  Lung       Date:  2015-05-06       Impact factor: 2.584

6.  Comparison of MGIT and Myco/F lytic liquid-based blood culture systems for recovery of Mycobacterium tuberculosis from pleural fluid.

Authors:  Elizabeth Harausz; John Kafuluma Lusiba; Mary Nsereko; John L Johnson; Zahra Toossi; Sam Ogwang; W Henry Boom; Moses L Joloba
Journal:  J Clin Microbiol       Date:  2015-02-04       Impact factor: 5.948

7.  Pleural tuberculosis: a key differential diagnosis for pleural thickening, even without obvious risk factors for tuberculosis in a low incidence setting.

Authors:  Keir Elmslie James Philip; Onn Min Kon; Mary Roddie; Clare Ross
Journal:  BMJ Case Rep       Date:  2018-10-27

8.  Repeatability of pleural adenosine deaminase measurements in diagnostic evaluation of pleural effusions.

Authors:  Ourania S Kotsiou; Panagiota Tzortzi; Rafailia A A Beta; Athanasios Kyritsis; Konstantinos I Gourgoulianis
Journal:  J Clin Lab Anal       Date:  2017-12-07       Impact factor: 2.352

9.  Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis.

Authors:  José Francisco García-Rodríguez; N Valcarce-Pardeiro; H Álvarez-Díaz; A Mariño-Callejo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-03       Impact factor: 3.267

10.  Myelomatous pleural effusion as an initial sign of multiple myeloma-a case report and review of literature.

Authors:  Li-Li Zhang; Yuan-Yuan Li; Cheng-Ping Hu; Hua-Ping Yang
Journal:  J Thorac Dis       Date:  2014-07       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.